Johns Hopkins Medicine Office of Continuing Medical Education
Skip Navigation.
How ToAbout CMECME CalendarOnline/EnduringProgramsResources & DownloadsContact & Travel InformationBlog
CME Online Log In
Forgot your password?

New to Hopkins CME?

Create a new account.

80027967: The Nicholas Fortuin Cardiovascular Topics at Johns Hopkins

February 14-16, 2013
  • Download Brochure
  • Send to Colleague
  • Back to List
The Nicholas Fortuin Cardiovascular Topics at Johns Hopkins Brochure Cover Image


ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 19.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDIT
American Academy of Family Physicians
This Live activity, The Nicholas Fortuin Cardiovascular Topics at Johns Hopkins, with a beginning date of February 14, 2013, has been reviewed and is acceptable for up to 19.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of Physician Assistants
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 19.0 hours of Category 1 credit for completing this program.


Registration From

Tuition Remission Form


DESCRIPTION

This symposium is clinically oriented, including case presentations, updates on clinical practice and reviews of multi-center trials data, and it emphasizes the scientific underpinnings of a cardiology practice. Subjects range from muscle mechanics in the fruit fly to clinical lipid management, given by a faculty who are in day-to-day practice, drawn from the Hopkins Cardiology Division and related specialties of cardiac and vascular surgery, neurology and endocrinology. Our small group workshop sessions offer the opportunity to bring interesting or problem cases to stump or share with our clinical experts. As in previous years, we offer an ACLS training and certification module.

OBJECTIVES

After attending this course, the participant will demonstrate the ability to:

  • Evaluate and manage patients with atrial fibrillation
  • Select patients who might benefit from trans-arterial valve replacement
  • Advise patients on the most updated information on potential side effect of statin drugs
  • Identify and manage patients with heart failure who could benefit from the use of inotropic agents
  • List current guidelines for treating cardiovascular risk factors.

Talks

February 14, 2013  8:00 AM to 12:00 PM

Moderator

Traill, Thomas
n/a
February 14, 2013  8:00 AM to 8:30 AM

Fixing Funny Flutters

Berger, Ronald
Recognize different forms of atrial flutter and appropriate management schemes for these arrhythmias
February 14, 2013  8:30 AM to 9:00 AM

Ventricular Tachycardia

Nazarian, Saman
Discuss types of ventricular tachycardia for (Premature Ventricular Contractions, Idiopathic Ventricular Tachycardia, Ventricular Tachycardia in Structural Heart Disease and Ventricular Fibrillation ) for which catheter ablation is an option.
February 14, 2013  9:00 AM to 9:30 AM

Guidelines for Managing Inherited Arrhythmias

Tomaselli, Gordon
To state the guidelines for the management of inherited arrhythmias
February 14, 2013  10:00 AM to 10:30 AM

Hypertrophic Cardiomyopathy and the Electrophysiologist

Marine, Joseph
1. Risk stratify patients with hypertrophic cardiomyopathy for ICD therapy based on current evidence and guidelines. 2. Select appropriate treatment strategies for patients with hypertrophic cardiomyopathy and atrial fibrillation. 3. Select appropriate treatment strategies for patients with hypertrophic cardiomyopathy and ventricular tachycardia.
February 14, 2013  10:30 AM to 11:00 AM

How to Get the Most Out of a Pacemaker

Spragg, David
Discuss optimal pacemaker programming in a range of implantable devices.
February 14, 2013  11:00 AM to 11:30 AM

Statins, Muscle Pain and Polymyositis

Mammen, Andrew
Recognize and manage various forms of statin-associated muscle pain and weakness.
February 14, 2013  11:30 AM to 12:00 PM

Clinical Rounds

Traill, Thomas
use clinical judgement to evaluate physical and laboratory findings in a patient with heart dysfunction Distinguish hemodynamic subtypes of valvular heart disease
February 14, 2013  1:00 PM to 2:30 PM

Moderator

Maughan, W Lowell
February 14, 2013  1:00 PM to 1:30 PM

Heart Failure: A PKGarious Balancing Act

Kass, David
List the pathways involving protein kinase G in the heart and how it can be activated using drug therapies State ways in which PKG signaling is changed by heart disease and its implications for that disease Discuss what human and other trials testing benefits from PDE5 inhibitors in heart failure are revealing
February 14, 2013  1:30 PM to 2:00 PM

The ATP-IV Guidelines: Is this the Right Direction?

Jones, Steven
Discuss the evolution of the new NCEP/ATP guidelines and new clinical research forming the basis for revisions in ATP-III
February 14, 2013  2:00 PM to 2:30 PM

Stem Cells: Less in the News Nowadays but More in the Substance

Johnston, Peter
DIscuss the current state of stem cell therapy for the heart
February 14, 2013  2:30 PM to 3:00 PM

Clinical Rounds

Ziegelstein, Roy
Appraise the evidence related to several case scenarios likely to confront cardiologists and primary care providers in clinical practice Define treatment strategies for several common heart conditions
February 14, 2013  3:20 PM to 4:20 PM

Advanced Cardiac Life Support Certification Course (ACLS)

Halperin, Henry
1. Discuss how to treat the first 10 minutes of cardiac arrest 2. State current recommendations for treating cardiac arrest.
February 14, 2013  3:20 PM to 4:20 PM

Workshop A. Prevention and Risk Management Strategies

Blumenthal, Roger
1. Review existing cholesterol and risk assessment guidelines. 2. Examine controversies that are being debated by NHLBI Guideline Panel. 3. Employ a comprehensive "ABCDE" approach to primary and secondary prevention of cardiovascular disease events.
February 14, 2013  3:20 PM to 4:20 PM

Workshop B. Peripheral Artery Disease

Ratchford, Elizabeth
Interpret non-invasive vascular studies for diagnosis of PAD Utilize an evidence-based approach for the medical management of PAD
February 14, 2013  3:20 PM to 4:20 PM

Workshop C. Echocardiography

Mayer, Susan
1. Recognize cardiac masses and discuss the differential 2. Identify an aortic dissection 3. Evaluate diastolic function 4. Diagnose prosthetic heart valve dysfunction
February 14, 2013  3:20 PM to 4:20 PM

Workshop D. Cardiac CT

Bush, David
Discuss current major indications for cardiac CT. Identify patients most likely to be suitable or unsuitable for cardiac CT evaluation. Describe major advances that permit cardiac CT to be performed with low radiation dose.
February 14, 2013  3:20 PM to 4:20 PM

Workshop E. Cardiovascular Disease in Women

Brennan, Margaret
Discuss cardiovascular disease in women
February 15, 2013  8:00 AM to 8:30 AM

Managing Patients with Pulmonary Hypertension due to Left Heart Disease

Tedford, Ryan
1) Recognize how to diagnose and classify pulmonary hypertension in the setting of heart failure 2) Describe the difference between passive and reactive pulmonary hypertension 3) Discuss potenital strategies for symptoms relief and treatment
February 15, 2013  8:30 AM to 9:00 AM

New Hopes and Approaches for Patients with Cardiac Amyloidosis

Judge, Daniel
1. Recognize the different causes for cardiac amyloidosis. 2. Describe established and emerging treatments for this condition.
February 15, 2013  9:00 AM to 9:30 AM

Using Inotropic Agents in Heart Failure

Russell, Stuart
Recognize appropriate indications and contraindications for the use of inotropic therapy State the results of clinical trials with inotropic therapy
February 15, 2013  9:30 AM to 10:00 AM

Heart Failure Readmissions: Taking Care of the Frequent Flyer

Kasper, Edward
Discuss what precipitates most readmissions after an index hospitalization for heart failure Discuss the lifetime risk for readmission Describe management of Heart Failure Disease Management 4. 30-day readmission rate – is this something we should really be measuring?
February 15, 2013  10:30 AM to 11:00 AM

Growth Hormone and the Heart

Salvatori, Roberto
Examine the consequences of growth hormone deficiency and growth hormone excess on the function of the heart
February 15, 2013  11:00 AM to 11:30 AM

Cardiotoxicity of Cancer Treatments Old and New

Aversano, Thomas
State the cardiotoxicity of traditional chemotherapeutic agents and the cardiotoxicity of newer chemotherapeutic agents Discuss the mechanism of cardiotoxicity of traditional and new chemotherapeutic agents.
February 15, 2013  11:30 AM to 12:00 PM

CCU Rounds

Schulman, Steven
Review current data for hypothermia for cardiac arrest patients, which patients benefit and which patients do not, and indications for revascularization.
February 15, 2013  1:00 PM to 5:30 PM

Moderator

Traill, Thomas
n/a
February 15, 2013  1:00 PM to 1:30 PM

Using Fly Hearts to Explore Molecular Regulation of the Cardiac Cycle

Cammarato, Anthony
Discuss the molecular basis of contractile regulation Explain ongoing efforts, using Drosophila, to delineate conserved mechanisms of troponin-induced cardiomyopathy
February 15, 2013  1:30 PM to 2:00 PM

State PCI Databases: Maryland and New York Experiences

Walford, Gary
Examine the policy issues behind the formation of State databases State the pros and cons of having a State database Explain the mechanism by which data is gathered and analyzed Discuss the issue of unintended consequences of public reporting Discuss the future use and misuse of State databases
February 15, 2013  2:00 PM to 2:30 PM

Anticoagulation in the CCUHeart Failure

Mclean, Rhondalyn
Review the changes in guidelines regarding anticoagulation in emergent situations Discuss the challenges of anticoagulation in the CCU setting Discuss specific cases where these challenges are highlighted
February 15, 2013  2:30 PM to 3:00 PM

Angio Rounds

Brinker, Jeffrey
Discuss the role of invasive and non-invasive angiography in the evaluation of patients thought to have significant coronary disease. State the differences and complimentary roles of angiography and intra-coronary physiologic assessment of specific arterial obstructions. Explain why coronary disease may be present without obvious obstructions on angiography. State the importance of angiographic techniques in demonstrating abnormalities of the coronary arteries and their appropriate treatment.
February 15, 2013  3:15 PM to 5:30 PM

Clinical Problem-Solving Group Symposium

Cameron, Duke
February 15, 2013  3:15 PM to 5:30 PM

Clinical Problem-Solving Group Symposium

Kasper, Edward
Discuss interesting cases
February 15, 2013  3:15 PM to 5:30 PM

Clinical Problem-Solving Group Symposium

Schulman, Steven
Review unusual presentations of several CCU patients, discuss evaluation and management.
February 15, 2013  3:15 PM to 5:30 PM

Clinical Problem-Solving Group Symposium

Traill, Thomas
correlate disparate sources of information in evaluating puzzling patient presentations
February 16, 2013  8:00 AM to 12:00 PM

Moderator

Traill, Thomas
n/a
February 16, 2013  8:00 AM to 8:30 AM

Multi-System Disease and the Heart Valves: Unusual Causes of Aortic Regurgitation

Cingolani, Oscar
Describe the most prevalent systemic diseases that can affect the aortic valve. Recognize and discuss different treatment options for such diseases.
February 16, 2013  8:30 AM to 9:00 AM

Role of CT Coronary Angiography in the Emergency Rooms

George, Richard
use coronary CT angiography in low to intermediate risk patients presenting to the emergency department with chest pain.
February 16, 2013  9:00 AM to 9:30 AM

Endovascular Aneurysm Repair

Abularrage, Christopher
discuss the long-term outcomes of endovascular abdominal aortic aneurysm repair (EVAR).
February 16, 2013  9:30 AM to 10:00 AM

Minimally Invasive Cardiac Surgery: Who, When and How?

Mandal, Kaushik
Identify benefits of minimaly invasive cardiac surgery Identify appropriate patients who will be good candidates for minimally invasive cardiac surgery
February 16, 2013  10:15 AM to 10:45 AM

Curmudgeon Rounds

Thiemann, David
Recognize inappropriate beliefs about and uses of legacy medications such as nitroglycerin, ezetimibe, niacin, and omega-3 fatty acids. Distinguish between real and fictional drug interactions and side effects for medications such as clopidogrel and statins. Identify appropriate indications and prescribing patterns for under-used medications such as aldosterone antagonists.
February 16, 2013  10:45 AM to 11:15 AM

Update on the TAVI Revolution

Resar, Jon
To list appropriate indications for consideration for transcatheter aortic valve replacement in patients with symptomatic aortic stenosis.
February 16, 2013  11:15 AM to 12:00 PM

Cardiac Surgery Rounds

Cameron, Duke
Describe the commercially available prosthesis for cardiac valve replacement Discuss the pros and cons of biologic versus mecahnical prostheses Recognize likely future developments in valve technology.

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.

Event Information
Johns Hopkins School of Medicine, Turner Auditorium
720 Rutland Ave
Baltimore, MD
Directions

Registration Fee(s)

Physicians – $ 475.00
Residents,Fellows, AHP – $ 250.00

Target Audience(s)

This annual activity is intended for cardiologists, internists and general practitioners seeking a comprehensive review of the year’s most topical issues.

Course Director

W Lowell Maughan

Course Co-Director

Edward Kasper
Thomas Traill

Lodging

Renaissance Harborplace Hotel
202 East Pratt Street
Baltimore, Maryland 21202
Phone: (800) 468-3571 or
(410) 547-1200
Fax: (410) 539-5780

Contact Info

General Info: 410.502.9634

Mailing Address:
Johns Hopkins University School
of Medicine
Thomas B. Turner Building
720 Rutland Avenue, Room 20
Baltimore, Maryland 21205-2195

Email Us

© 2013 Johns Hopkins University
School of Medicine | Office of Continuing Medical Education
Home | Privacy Policy | Sitemap
Managed Hosting by PEER 1
HTML to PDF conversion by ABCpdf.NET